Premier Biomedical, Inc. is a research-based company, which engages in the development and discovery of medical products. The company is headquartered in Whitefish, Montana. The company went IPO on 2012-02-23. The firm has developed a line of topical hemp oil pain relief products. The firm develops medical treatments for humans, specifically focusing on the treatment of Cancer Fibromyalgia, Traumatic Brain Injury (TBI), Alzheimer’s Disease (AD), Blood Sepsis and Viremia, Feldetrex. The firm offers eight pain relief products: 96-hour pain relief patch with 50 mg of hemp oil extract, 120 milligram (mg)/ 10 milliliter (ml) water-based roll-on applicator; 150 mg/ 30 ml oil-based pump spray applicator; 150 mg/ 2 oz. ointment; 200 mg/10 ml oil-based roll-on applicator; 500 mg/ 30 ml oil-based pump-spray applicator, and 500 mg/ 1 oz. ointment. The company offers extra-corporeal treatment of disease, PTSD treatment, anti-breast cancer drugs, hemp oil, anti-aging treatments and chemical and alcohol addiction treatment.

Industry: Biological Products, (No Diagnostic Substances) Peers: ACTAVIA LIFE SCIENCES, INC. GlobeStar Therapeutics Corp GridAI Technologies Corp Endonovo Therapeutics Inc Innoveren Scientific, Inc. Q BioMed Inc.